News

Aspire, thrombectomy, C. Dorn Smith, aspirators, clot, cold leg, removal

C. Dorn Smith, M.D., vascular surgeon in Kingstree, South Carolina, was successful in using a new device to remove blood clots from a patient with a cold leg using the Aspire mechanical...

Biotronik, Pulsar-18, Michael Lichtenberg, study

Biotronik announced the publication of promising clinical results regarding its Pulsar-18 stent platform. Adding to the similarly encouraging data collected in the earlier 4EVER and PEACE...

Cordis Corp., Cordis Crossing Portfolio, Elitecross, Outback Elite, CTO

Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe and Japan. This expands the Cordis...

Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results

AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose aspirin, at the American College of...

Penumbra, ACE64, aspiration thrombectomy, acute ischemic stroke, FDA

Penumbra Inc. announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the U.S. Food and Drug Administration for the revascularization of large...

Fantom, REVA Medical, FANTOM II trial, ACC

REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of its Fantom sirolimus-eluting bioresorbable scaffold in March. The scaffold, made from REVA's...

Medtronic, Euphora SC balloon, CE Mark, Europe, Richard Edwards

Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries that recognize the CE (Conformité Européene) mark in February. The first patient case with...

Merit Medical, Prelude Snap, splittable sheath introducer

Merit Medical Systems Inc. announced the launch of the Prelude Snap splittable sheath introducer.

Accreditation for Cardiovascular Excellence (ACE)

The Accreditation for Cardiovascular Excellence (ACE) is the exclusive international provider of interventional cardiology, electrophysiology, congenital heart disease and endovascular...

corpath, corindus, cath lab robot, robotics PCI

Long-term exposure to ionizing radiation is a primary occupational concern for today's interventional cardiologists. To address these concerns, many interventional cardiologists are enlisting the...

IABP, peer review, Maquet, Journal of Invasive Cardiology

Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps (IABPs) versus...

enroute carotid stent

Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k) clearance for its Enroute transcarotid neuroprotection system (NPS). The Enroute transcarotid...

electronic stents, bioresorbable electronic stent, BES

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic stents” to monitor a treated lesion...

OrbusNeich, Combo, EPC, HARMONEE study, U.S.

OrbusNeich has announced that the first U.S. patient has been enrolled in the HARMONEE (Harmonized Assessment by Randomized, Multi-center Study of OrbusNEich's COMBO StEnt) stent study. The study...

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock

Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA Capital, Deerfield, Sectoral Asset...

Boston Scientific, Lotus, PVL, RESPOND, REPRISE II, EuroPCR 2015

A new study evaluating the Boston Scientific Lotus Valve System demonstrated an extremely low rate of paravalvular aortic regurgitation (leakage) for a transcatheter aortic replacement valve....

ART, PBS, pure bioresorbable scaffold, CE Mark

Privately-held company Arterial Remodeling Technologies (ART) announced CE Mark clearance for its next-generation drug-free, pure bioresorbable scaffold used to treat coronary artery disease. The...

St. Jude Medical, OCT, PCI, ILUMIEN, EuroPCR 2015

St. Jude Medical Inc. announced preliminary results from the ILUMIEN I trial and final results from the ILUMIEN II clinical study. Taken together, the findings from both studies show that with...

Visipaque, IOCM, LOCM, angioplasty, EuroPCR 2015

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque (iodixanol) than those using low-osmolar contrast...

Boston Scientific, Synergy, EVOLVE I, EVOLVE II, EuroPCR 2015, results

Boston Scientific reported positive, long-term data from the EVOLVE Trial of the Synergy everolimus-eluting bioabsorbable polymer platinum chromium coronary stent system, with no new major adverse...